文献速递皮肤肿瘤

激光辅助光动力疗法治疗表浅基底细胞癌与鲍温病:连续与点阵消融CO2激光模式的随机患者内比较

Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO2 laser mode.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2018-07-17

本研究在15例无法手术、组织学确诊的表浅基底细胞癌或鲍温病患者中,对30个治疗区域进行患者内随机分组,比较连续与点阵消融CO2激光辅助氨基酮戊酸甲酯光动力疗法的疗效、疼痛、副作用和美观。12个月时两种模式疗效均为92.9%(表浅基底细胞癌100%,鲍温病80%),未建立等效性;点阵组第二次治疗时疼痛显著更轻(P=0.026),副作用和美观无显著差异。

要点

  • 点阵激光辅助光动力疗法在第二次治疗时疼痛显著轻于连续模式(P=0.026)。
  • 12个月疗效两种模式均为92.9%,但等效性分析未能建立等效。
  • 副作用和美观评分两种模式无显著差异。

核心结论

  • 这项先导研究结果支持激光辅助光动力疗法的前景,两种模式疗效相同、副作用和美观相当。
  • 点阵激光辅助光动力疗法组光动力照射疼痛显著更轻,提示偏好点阵模式。
  • 作者建议在偏好某一种技术前需进一步研究,包括更大样本量、表浅基底细胞癌与鲍温病之间的亚组分析以及不同治疗方案的比较。

研究设计与样本

  • 患者内随机对照先导研究,纳入15例无法手术、组织学确诊的表浅基底细胞癌或鲍温病患者,共30个治疗区域。
  • 治疗区域经患者内随机分配接受连续或点阵消融CO2激光,随后涂抹氨基酮戊酸甲酯,3小时后照射,2周后重复治疗。
  • 主要终点为疗效,采用等效性分析;次要终点疼痛、副作用和美观采用配对样本检验评估。

主要发现

  • 12个月时连续激光辅助光动力疗法和点阵激光辅助光动力疗法疗效均为92.9%(表浅基底细胞癌100%,鲍温病80%)。
  • 等效性未能建立。
  • 点阵激光辅助光动力疗法组疼痛更轻,第二次治疗时差异显著(P=0.026)。
  • 副作用轻至中度,最常见即刻副作用为红斑,其次为水肿、结痂和烧灼感。
  • 色素改变发生率连续组为21%、点阵组为29%,美观在所有患者中为良好至优秀。

关键数值与推荐

  • 12个月疗效:连续激光辅助光动力疗法和点阵激光辅助光动力疗法均为92.9%(表浅基底细胞癌100%,鲍温病80%)。
  • 第二次治疗疼痛:点阵激光辅助光动力疗法显著轻于连续激光辅助光动力疗法(P=0.026)。
  • 副作用比较P=0.219-1.000,美观比较P=0.157-1.000。
  • 色素改变:连续激光辅助光动力疗法组21%,点阵激光辅助光动力疗法组29%。

临床怎么用

  • 作者认为点阵激光辅助光动力疗法组光动力照射疼痛显著更轻,提示偏好点阵模式。
  • 作者建议进一步研究更大样本量、表浅基底细胞癌与鲍温病亚组分析及不同治疗方案比较后,才能偏好某一种技术。

局限性

  • 原文称本研究为先导研究。
  • 作者建议需进一步研究更大样本量。
  • 作者建议需进一步进行表浅基底细胞癌与鲍温病之间的亚组分析。
  • 作者建议需进一步比较不同治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laser-assisted photodynamic therapy is being explored as a method to enhance efficacy of photodynamic therapy (PDT). OBJECTIVE: To compare a continuous (CL) and a fractional (FL) ablative CO2 laser-assisted methyl aminolevulinate (MAL) PDT in the management of superficial basal cell carcinoma (sBCC) and Bowen's disease (BD). METHODS: Thirty treatment areas in fifteen patients with inoperable, histologically verified sBCC or BD received CL or FL after intrapatient randomization. Laser treatment was followed by MAL application and illumination occurred 3 h later. This treatment was repeated after 2 weeks. An equivalence analysis was performed on the primary endpoint efficacy, while secondary endpoints pain, side-effects and aesthetics were evaluated using paired samples tests. Patients were also asked for their preferred treatment. RESULTS: An excellent efficacy of 92.9% (sBCC, 100%; BD, 80%) was found in both CL + PDT and FL + PDT after 12 months. Equivalence could not be established. Little pain was perceived in most patients during PDT illumination. PDT treatment in FL + PDT was less painful, significantly during the second treatment (P = 0.026). Side-effects were mild to moderate with erythema being the most frequent immediate side-effect, followed by oedema, crusting and burning sensation. Pigmentary changes occurred in 21% (CL + PDT) to 29% (FL + PDT), and aesthetics were good to excellent in all patients. CL + PDT and FL + PDT did not significantly differ in side-effects (P = 0.219-1.000) or aesthetics (P = 0.157-1.000). CONCLUSIONS: Results in this pilot study support the promising role of laser-assisted PDT. Both treatment arms demonstrated the same efficacy as well as comparable side-effects and aesthetics. PDT illumination was significantly less painful in the FL + PDT group, suggesting a preference for FL + PDT. The authors recommend further investigation with a larger sample size, a subgroup analysis between sBCC and BD and comparison of different treatment protocols before one technique could be preferred to another.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Genouw E, Verheire B, Ongenae K, et al. Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO2 laser mode. J Eur Acad Dermatol Venereol. 2018. PMID: 29633367. doi:10.1111/jdv.14989

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。